Literature DB >> 25900209

Connective tissue diseases: The burden of serious infections in SLE.

Jessica Widdifield1, Sasha Bernatsky1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25900209     DOI： 10.1038/nrrheum.2015.55

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  10 in total

Review 1.  Infections in systemic lupus erythematosus and rheumatoid arthritis.

Authors:  E Bouza; J G Moya; P Muñoz
Journal:  Infect Dis Clin North Am       Date:  2001-06       Impact factor: 5.982

2.  Premature Mortality: A Neglected Outcome in Rheumatic Diseases?

Authors:  Theodore Pincus; Kathryn A Gibson; Joel A Block
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-08       Impact factor: 4.794

3.  EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases.

Authors:  S van Assen; N Agmon-Levin; O Elkayam; R Cervera; M F Doran; M Dougados; P Emery; P Geborek; J P A Ioannidis; D R W Jayne; C G M Kallenberg; U Müller-Ladner; Y Shoenfeld; L Stojanovich; G Valesini; N M Wulffraat; M Bijl
Journal:  Ann Rheum Dis       Date:  2010-12-03       Impact factor: 19.103

4.  Burden of Serious Infections in Adults With Systemic Lupus Erythematosus: A National Population-Based Study, 1996-2011.

Authors:  Maria G Tektonidou; Zhong Wang; Abhijit Dasgupta; Michael M Ward
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-08       Impact factor: 4.794

5.  Reasons for failure to receive pneumococcal and influenza vaccinations among immunosuppressed patients with systemic lupus erythematosus.

Authors:  Erica F Lawson; Laura Trupin; Edward H Yelin; Jinoos Yazdany
Journal:  Semin Arthritis Rheum       Date:  2015-01-22       Impact factor: 5.532

6.  Infectious disease hospitalizations among older adults in the United States from 1990 through 2002.

Authors:  Aaron T Curns; Robert C Holman; James J Sejvar; Maria F Owings; Lawrence B Schonberger
Journal:  Arch Intern Med       Date:  2005-11-28

Review 7.  Systemic lupus erythematosus and infections: clinical importance of conventional and upcoming biomarkers.

Authors:  S Sciascia; L Ceberio; C Garcia-Fernandez; D Roccatello; Y Karim; M J Cuadrado
Journal:  Autoimmun Rev       Date:  2012-04-01       Impact factor: 9.754

8.  Overall and cause-specific mortality in patients with systemic lupus erythematosus: a meta-analysis of observational studies.

Authors:  Marko Yurkovich; Kateryna Vostretsova; Wenjia Chen; J Antonio Aviña-Zubieta
Journal:  Arthritis Care Res (Hoboken)       Date:  2014-04       Impact factor: 4.794

9.  EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics.

Authors:  G Bertsias; J P A Ioannidis; J Boletis; S Bombardieri; R Cervera; C Dostal; J Font; I M Gilboe; F Houssiau; T Huizinga; D Isenberg; C G M Kallenberg; M Khamashta; J C Piette; M Schneider; J Smolen; G Sturfelt; A Tincani; R van Vollenhoven; C Gordon; D T Boumpas
Journal:  Ann Rheum Dis       Date:  2007-05-15       Impact factor: 19.103

Review 10.  How can we reduce the risk of serious infection for patients with systemic lupus erythematosus?

Authors:  Diane L Kamen
Journal:  Arthritis Res Ther       Date:  2009       Impact factor: 5.156
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.